Carboxamide compounds and methods for using the same
    12.
    发明授权
    Carboxamide compounds and methods for using the same 有权
    羧甲酰胺化合物及其使用方法

    公开(公告)号:US08362235B2

    公开(公告)日:2013-01-29

    申请号:US12695861

    申请日:2010-01-28

    CPC分类号: C07D401/12 C07D401/14

    摘要: Disclosed are carboxamide compounds as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure in which R1, R2, R3, R4, T, p, q, w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.

    摘要翻译: 公开了羧酰胺化合物以及药物组合物和使用方法。 一个实施方案是具有其中R 1,R 2,R 3,R 4,T,p,q,w和x如本文所述的结构的化合物。 在某些实施方案中,本文公开的化合物激活AMPK途径,并且可用于治疗与代谢有关的病症和病症。

    CARBOXAMIDE COMPOUNDS AND METHODS FOR USING THE SAME
    15.
    发明申请
    CARBOXAMIDE COMPOUNDS AND METHODS FOR USING THE SAME 有权
    羧酰胺化合物及其使用方法

    公开(公告)号:US20100190802A1

    公开(公告)日:2010-07-29

    申请号:US12695861

    申请日:2010-01-28

    CPC分类号: C07D401/12 C07D401/14

    摘要: Disclosed are carboxamide compounds as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure in which R1, R2, R3, R4, T, p, q, w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.

    摘要翻译: 公开了羧酰胺化合物以及药物组合物和使用方法。 一个实施方案是具有其中R 1,R 2,R 3,R 4,T,p,q,w和x如本文所述的结构的化合物。 在某些实施方案中,本文公开的化合物激活AMPK途径,并且可用于治疗与代谢有关的病症和病症。

    Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses
    20.
    发明授权
    Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses 有权
    包含可代谢部分的杂环抗病毒化合物及其用途

    公开(公告)号:US07498353B2

    公开(公告)日:2009-03-03

    申请号:US11381215

    申请日:2006-05-02

    IPC分类号: A01N43/80 A61K31/42

    CPC分类号: C07D261/08 C07D413/04

    摘要: The present invention relates to prodrugs and compositions thereof useful for treating or preventing Hepatitis C virus (HCV) infections. In particular, the present invention relates to prodrugs of substituted diphenyl-, diheteroaryl- and mixed phenyl heteroaryl substituted five-membered heterocycle compounds, compositions comprising the compounds and the use of such compounds and compositions to inhibit HCV replication and/or proliferation as a therapeutic approach towards the treatment and/or prevention of HCV infections in humans and animals.

    摘要翻译: 本发明涉及可用于治疗或预防丙型肝炎病毒(HCV)感染的前药及其组合物。 特别地,本发明涉及取代的二苯基 - ,二杂芳基 - 和混合苯基杂芳基取代的五元杂环化合物的前药,包含该化合物的组合物以及这些化合物和组合物用于抑制HCV复制和/或增殖作为治疗剂 在人和动物中治疗和/或预防HCV感染的方法。